Both the ghrelin and motilin receptor have been investigated as therapeutic targets for digestive disorders, but no compounds with selective activity are yet in clinical use Ligand-dependent ...
KOSAN Biosciences Announces License Of Motilin Agonist Program To Pfizer; Kosan Will Receive Upfront Payment $12.5M; Additional Milestone Payments Up To $250M HAYWARD, Calif., Dec. 20 -- Kosan ...
You know a rumbling tummy is a sign you haven’t eaten in a while. But there’s a lot more going on down there than a quaking plea for more food. Like street sweepers cleaning up after a parade, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback